17Aug
UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By:
Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/
Related
When owners file bankruptcy or projects otherwise go south, lien priority often comes to the forefro...
Read More >
Bricker education attorneys Nicole Donovsky, David Lampe and Beverly Meyer summarize the most import...
Read More >
The Colorado Department of Labor and Employment’s Division of Labor Standards and Statistics has re...
Read More >
The United States Supreme Court finally clarified its 11-year-old “clear evidence” standard for ph...
Read More >
On 14 January 2021, German Parliament passed a comprehensive reform of the German Act against Restra...
Read More >
To further implement the Foreign Investment Risk Review Modernization Act of 2018 (“FIRRMA”), the ...
Read More >